Skip to main content

Author: Bill Snyder

Technique hastens COVID-19 antibody discovery

Mar. 10, 2022—Optimization of a technique developed at Vanderbilt University Medical Center enables rapid and efficient identification of neutralizing monoclonal antibodies against the virus that causes COVID-19.

Read more


Brain function expert Deisseroth set for March 17 Discovery Lecture

Mar. 10, 2022—Optogenetics pioneer Karl Deisseroth, MD, PhD, will speak at Vanderbilt's upcoming Discovery Lecture on Thursday, March 17.

Read more


Research Staff Awards honor those who help drive science forward

Mar. 9, 2022—Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony.

Read more


Former Karolinska Institute chair Norrby set for March 14 lecture

Mar. 8, 2022—Erling Norrby, MD, PhD, a world authority on viruses and former chair at the Karolinska Institute in Stockholm, Sweden, will deliver a lecture at Vanderbilt University Medical Center on Monday, March 14.

Read more


COVID-19: two years of challenges, lessons, victories

Mar. 3, 2022—Two years ago this week, the cataclysmic coronavirus known as SARS-CoV-2 arrived in Middle Tennessee.

Read more


VUMC researchers find clue to drug-induced arrhythmias

Feb. 24, 2022—Vanderbilt University Medical Center researchers have made a fundamental discovery about how the heart compensates for genetic variations that otherwise could trigger abnormal and potentially fatal heart rhythms.

Read more


Pandemic leads to broader use of monoclonal antibodies

Feb. 17, 2022—Antiviral drugs and coronavirus-fighting monoclonal antibodies, including those discovered at Vanderbilt University Medical Center, remain crucially important in the continuing fight against COVID-19.

Read more


Diverticulitis surgery: guidelines needed

Feb. 10, 2022—Surgical removal of the colon for recurrent diverticulosis varies by geographic region and is associated with surgeon and hospital factors; stronger national guidelines are needed, Vanderbilt researchers report.

Read more


Halasa, Jordan, Wilkins elected members of ASCI

Feb. 10, 2022—Three Vanderbilt faculty members have been elected this year to membership in the American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry.

Read more


VUMC study raises hope for improving treatment of kidney disease

Feb. 2, 2022—Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure.

Read more


Accelerating podocyte production

Feb. 1, 2022—A new method developed by Vanderbilt researchers to generate kidney cells from stem cells offers a faster and less expensive way to make these valuable tools for studying kidney diseases.

Read more


Omicron evades some but not all monoclonal antibodies: study

Jan. 20, 2022—A new study found that several, but not all, of the human monoclonal antibodies used clinically to prevent patients from becoming severely ill from COVID-19 may not be protective against the Omicron variant now sweeping across the United States.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more